Teva North America recalls Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUT
Recalled August 3, 2016 · FDA recall D-1449-2016 · Teva North America
Hazard
Failed Tablet/Capsule Specifications · FDA Class III
Units
14, 370 units
Sold at
Nationwide and Puerto Rico
Description
Failed Tablet/Capsule Specifications
Product
Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.
Manufacturer(s)
Teva North America
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →